drugset / Trial / NCT02324153
Ramelteon in the Prevention of Post-operative Delirium
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This trial focuses on a Phase II randomized masked clinical trial testing the effectiveness and safety of peri-operative administration of ramelteon, a melatonin agonist in the prevention of postoperative delirium.
Timeline
- Start
- 2017-03-24
- Primary completion
- 2019-06-26
- Completion
- 2019-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 8 mg | Oral |
| Background | Riboflavin | Other / unclassified | 100 mg | — |